Literature DB >> 3918982

Binding of latamoxef (moxalactam) and its decarboxylated derivative to Escherichia coli and Pseudomonas aeruginosa penicillin-binding proteins.

R Labia, P Baron, J M Masson.   

Abstract

The binding of latamoxef (moxalactam) and of a decarboxylated derivative to Escherichia coli and Pseudomonas aeruginosa penicillin-binding proteins (PBPs) was measured by competition experiments with 125I-radiolabelled penicillin X. Latamoxef and the decarboxylated derivative were highly bound to most of the PBPs, with the exception of PBP-2. As the two compounds possess a phenolic side-chain, they also could be radiolabelled with 125I. The proteins thus labelled by these derivatives were qualitatively the same as those labelled by 125I-penicillin X, except for PBP-2 which was not labelled by the iodo derivatives of latamoxef and its decarboxylated derivative, and PBP-1c (in E. coli) which is labelled only poorly by the radioactive penicillin. No important difference between latamoxef and its decarboxylated derivative was found, and the same observation was made for penicillin G and carbenicillin. Thus, it was concluded that the carboxylic group of latamoxef does not play an important role in affinity for the targets.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3918982     DOI: 10.1093/jac/15.1.9

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  2 in total

1.  Interplay between chromosomal beta-lactamase and the MexAB-OprM efflux system in intrinsic resistance to beta-lactams in Pseudomonas aeruginosa.

Authors:  N Masuda; N Gotoh; C Ishii; E Sakagawa; S Ohya; T Nishino
Journal:  Antimicrob Agents Chemother       Date:  1999-02       Impact factor: 5.191

2.  First Penicillin-Binding Protein Occupancy Patterns of β-Lactams and β-Lactamase Inhibitors in Klebsiella pneumoniae.

Authors:  Dhruvitkumar S Sutaria; Bartolome Moya; Kari B Green; Tae Hwan Kim; Xun Tao; Yuanyuan Jiao; Arnold Louie; George L Drusano; Jürgen B Bulitta
Journal:  Antimicrob Agents Chemother       Date:  2018-05-25       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.